Search


The CEO of Maze Therapeutics' shares his perspective on FTC's scuttling of his company's licensing deal with Sanofi
Jason Coloma shares the smaller company's perspective of how a licensing deal was scuttled by the FTC.
Jan 8, 2024
Also look for unique social pages for BiotechTV U.
Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.